{"id":"W3171632039","doi":"10.1016/j.jtct.2021.05.004","title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report","year":2021,"lang":"en","type":"article","venue":"Transplantation and Cellular Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital","funders":"National Institutes of Health; Sapienza Università di Roma; CTI Biopharma; Meiji Seika Pharma; Dana-Farber Cancer Institute; Pfizer; CareDx; Government of South Australia; Janssen Pharmaceuticals; Gilead Sciences; Massachusetts General Hospital; Bristol-Myers Squibb; AstraZeneca; Novartis; Amgen; National Cancer Institute; Takeda Pharmaceutical Company","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Context (archaeology); Graft-versus-host disease; Systemic therapy; Chronic disease; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002268956,0.0001580045,0.0006663429,0.00008178609,0.00006790298,0.000008402855,0.00003583829,0.00006956967,0.00005772425],"category_scores_gemma":[0.00007381938,0.0001103706,0.0001703251,0.0001472061,0.0001005595,0.0000215004,0.000001391336,0.00005990404,8.171411e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001926941,"about_ca_system_score_gemma":0.003389374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003403631,"about_ca_topic_score_gemma":0.00007499225,"domain_scores_codex":[0.9972236,0.0005610447,0.001466425,0.0002891423,0.0003099222,0.0001498715],"domain_scores_gemma":[0.9981017,0.001148209,0.0003897884,0.0001536212,0.0001412512,0.00006540262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1283776,0.01512547,0.03229736,0.02633397,0.006709159,0.003488276,0.05121304,0.0004678952,0.326156,0.01224395,0.001268561,0.3963187],"study_design_scores_gemma":[0.1249931,0.00810239,0.1636586,0.002360011,0.0008143213,0.0003630706,0.001077063,0.001508914,0.6676159,0.000162745,0.02869004,0.0006538443],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9818199,0.009893427,0.002991881,0.001775416,0.0004445038,0.002715561,0.0001514545,0.00001923598,0.0001886767],"genre_scores_gemma":[0.9721143,0.02519302,0.0008269421,0.00009362882,0.0001327191,0.0001785802,0.001341392,0.00001666904,0.0001027933],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3956649,"threshold_uncertainty_score":0.6012603,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2395835741235416,"score_gpt":0.4655049099569021,"score_spread":0.2259213358333605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}